ArticlePharmaceutics2022

Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study.

Assem Ashimova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.